MAN1A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.4108718333955E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.80119999920936E-08 |
Normal-vs-Stage2 |
2.0017999999955E-05 |
Normal-vs-Stage3 |
1.05050412813057E-11 |
Normal-vs-Stage4 |
7.91344767492319E-12 |
Stage1-vs-Stage2 |
4.392600E-01 |
Stage1-vs-Stage3 |
4.398300E-03 |
Stage1-vs-Stage4 |
1.221040E-03 |
Stage2-vs-Stage3 |
2.493800E-01 |
Stage2-vs-Stage4 |
1.119590E-01 |
Stage3-vs-Stage4 |
5.012200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.44589928708206E-11 |
Normal-vs-AfricanAmerican |
7.82720555037031E-11 |
Normal-vs-Asian |
1.965160E-01 |
Caucasian-vs-AfricanAmerican |
2.146200E-02 |
Caucasian-vs-Asian |
3.072400E-01 |
AfricanAmerican-vs-Asian |
4.536500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.08300043880172E-11 |
Normal-vs-Female |
1.75619996323206E-09 |
Male-vs-Female |
4.564000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.77649999999874E-05 |
Normal-vs-Age(41-60Yrs) |
2.78689999966275E-08 |
Normal-vs-Age(61-80Yrs) |
4.52504700376721E-12 |
Normal-vs-Age(81-100Yrs) |
2.16129999996983E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.866400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.353400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.832400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.157400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.007000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.656000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.212000E-02 |
Normal-vs-Grade 2 |
8.76929999948928E-07 |
Normal-vs-Grade 3 |
3.75122155560348E-12 |
Normal-vs-Grade 4 |
1.69508851399769E-12 |
Grade 1-vs-Grade 2 |
5.797000E-01 |
Grade 1-vs-Grade 3 |
1.188020E-01 |
Grade 1-vs-Grade 4 |
6.843600E-03 |
Grade 2-vs-Grade 3 |
1.411690E-02 |
Grade 2-vs-Grade 4 |
2.19969999999403E-05 |
Grade 3-vs-Grade 4 |
2.171800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.02119999999084E-05 |
Normal-vs-ccB subtype |
8.72850014488336E-10 |
ccA subtype-vs-ccB subtype |
6.503600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.17180001655026E-09 |
Normal-vs-N1 |
1.002830E-03 |
N0-vs-N1 |
6.004000E-01 |
|
|